Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2863PDF: 1851HTML: 3694Pellagatti Fig 1: 228Pellagatti Fig. 2: 221 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3157PDF: 930HTML: 2090 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2376PDF: 1194HTML: 696 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3812PDF: 1617HTML: 586Figures . Eliassian: 235 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2632PDF: 819HTML: 5241 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1431HTML: 488PDF: 850 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2386PDF: 1677HTML: 305 -
Pseudo-differentiation syndrome
1406PDF: 680HTML: 10855Figure 1: peripheral blood showing myeloblasts with auer rods: 128Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 112Figure 3: CXR showing pulmonary infiltartes with consolidation: 140Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 122Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 122 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2214PDF: 1740HTML: 387 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4021PDF: 765HTML: 1858 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4876PDF: 1857HTML: 2172 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2021PDF: 988HTML: 704 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3864PDF: 1700HTML: 11661Figures Haase: 221 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3785PDF: 1503HTML: 190 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1862PDF: 1014HTML: 148 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1813PDF: 952HTML: 1117Untitled: 174Untitled: 191Untitled: 174Untitled: 175 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4445PDF: 3655HTML: 226 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1798PDF: 892HTML: 389Fig1: 248Fig.2: 261Fig. 3: 199Fig. 5: 211Fig. 4: 234 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2872PDF: 1035HTML: 5531 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1258PDF: 611HTML: 2874ATRA induced Reactive Hemophagocytosis: A Case Report: 209 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1863PDF: 838HTML: 10250Figures 1,2,3: 202 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1500PDF: 925Suppl. Files: 463HTML: 248 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1105PDF: 764HTML: 122 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7744PDF: 2456HTML: 1745Table 1.: 228Table 2.: 240Table 3.: 222Table 4.: 216 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1340PDF: 889HTML: 1160Coverletter: 226 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3569PDF: 909HTML: 1670figure 1: 174Untitled: 201 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13308PDF: 994HTML: 7300 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1293PDF: 535HTML: 23104 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2833PDF: 1005HTML: 648 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1820PDF: 557HTML: 16986Figure 4: 179Figure 3: 151Figure 2: 157Figure 1: 194 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1419PDF: 873HTML: 149 -
-
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1090PDF: 1196Suppl. Files: 575HTML: 94 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2337PDF: 1347HTML: 17105Bassan Fig.1: 154Bassan Fig.2: 174Bassan Fig.4: 146Fig.3: 215







